RxDoctor Payments DataLook up a doctor →

Jill Waibel, MD

Dermatology · Miami, FLNPI 1154347847

Payments from drug & device makers

$4,303,898in general payments, 2019–2025

Across 787 payments — averaging $5468.74 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Eli Lilly$2M
  • Pfizer$414K
  • Janssen Research & Development, LLC$393K
  • AbbVie$379K
  • Sanofi US Services Inc.$373K
  • Amgen$272K
  • plus $472K from 49 others
$76,778in research payments, 2019–2025

Across 10 payments — averaging $7677.77 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Eli Lilly$41K
  • Biofrontera Inc.$36K

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Eli Lilly106$2,001,207
Pfizer108$413,742
Janssen Research & Development, LLC24$393,354
AbbVie(2 entities)183$379,008
Sanofi US Services Inc.21$373,495
Amgen(2 entities)11$271,591
Argenx US, Inc.44$224,001
Astrazeneca UK Limited6$82,477
Avita Medical Americas, LLC5$49,630
Solta Medical, A Division Of Bausch Health US, LLC5$27,404
Novartis32$23,689
E.r. Squibb & Sons, L.L.C.5$22,697
Daiichi Sankyo Company LTD2$10,315
UCB SA2$5,445
Eli Lilly Export S.A. Puerto Rico Branch1$5,400
Lilly USA, LLC12$4,850
Ortho Dermatologics, A Division Of Bausch Health US, LLC13$3,113
Biofrontera Inc.5$2,070
Lumenis BE (hk) Limited1$2,000
Lumenis, Inc1$2,000
Lumenis BE Inc1$2,000
Galderma Laboratories, L.p.69$807
Almirall LLC1$600
Johnson & Johnson15$347
Regeneron Healthcare Solutions, Inc.13$292
Daiichi Sankyo Inc.5$224
LEO Pharma Inc.12$220
Boehringer Ingelheim8$219
Journey Medical Corporation16$214
Sun Pharmaceutical Industries Inc.8$185
Organogenesis Inc.3$158
Sanofi7$145
Sientra, Inc.1$132
AstraZeneca1$122
Access Pro Medical, LLC1$97
Strata Skin Sciences, Inc.8$95
Sebela Pharmaceuticals Inc.3$64
Dermira, Inc.3$59
Verrica Pharmaceuticals Inc.2$59
Arcutis Biotherapeutics, Inc.3$50
Mayne Pharma Commercial LLC4$35
EPI Health, LLC2$34
Mylan Pharmaceuticals Inc.2$29
Smith+Nephew1$23
Helsinn Therapeutics (U.S.), Inc.1$22
Promius Pharma LLC1$21
Incyte Corporation1$20
DUSA Pharmaceuticals, Inc.1$19
Acera Surgical, Inc.1$19
Nabriva Therapeutics, PLC1$19
Glenmark Therapeutics Inc.1$18
Nobelpharma America, LLC1$16
VYNE Pharmaceuticals Inc.1$16
Dermavant Sciences, Inc.1$15
Bristol Myers Squibb1$15

How this compares

$4,303,898 in reported general payments places this provider in the 95th percentile of 1,147 dermatology providers in Florida.

See all dermatology providers in Florida

Medicare billing

Part B allowed, 2024
$142,737
Medicare patients
316
Services billed
1,469

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other dermatology in Miami

See the full list for Florida

Where these figures come from

Is this you, or does something look wrong? →